Welcome to the Research section of IRFF Genome Institute. We are committed to advancing scientific knowledge across various domains. Please explore our research areas below to learn more about our specific projects and initiatives.
Developing innovative therapeutic drugs targeting neurodegenerative conditions like Alzheimer's and Parkinson's.
Researching new drugs to treat Rett Syndrome, focusing on genetic and molecular interventions.
Investigating genetic mutations and metabolic pathways in Leigh Syndrome to develop effective therapies.
Exploring the role of Natural Killer cells in combating viruses and cancer for enhanced immune therapies.
Developing AI-driven tools to track and analyze behavior in model organisms.
The BOOCS (a novel concept developed by professor Takehiko Fujino) could potentially rescue Brain Fatigue.
Developing cutting-edge tools and methodologies for advanced genomic research.
Utilizing CRISPR-Cas9 for precise genome editing to study genetic functions and therapies.
Creating advanced software tools for comprehensive gene expression and interaction analysis.
Studying plasmalogens as biomarkers for Alzheimer's, Parkinson's, and aging using advanced techniques.
Our Institute Developed nad Patented Plasmalogens Extraction Methods for use in Clinical Trials and Use as Supplements.
Exploring genetic and molecular mechanisms influencing longevity using C. elegans as a model organism.
Utilizing simulation techniques to model interactions between drug compounds and biological targets.
Modal content goes here.
